ActualEyes Inc. Companies
Last updated: March 15, 2021 ActualEyes has developed therapeutics and products for treating Fuchs' corneal endothelium dystrophy. The products developed are eyedrops, regenerative cell-therapy based products, and therapeutics such as AE001 (phase I) and AE002.
Technology:
Clinical Data Management
Industry:
Healthcare Innovations
Founded Date:
2018
Headquarters:
Kyoto, Kyoto, Japan